The Commonwealth Fund (2022) recommended that efforts to control drug pricing should focus on five areas:

  1. Helping government to become a more responsible purchaser.
  2. Stopping patent abuses and anticompetitive practices that block price competition.
  3. Building a sustainable biosimilar market to create price competition.
  4. Fixing incentives in the drug supply chain and making the supply chain more transparent.
  5. Ensuring public accountability in the government-funded drug development process.

What area, if any, is the most achievable in the short run ? Explain

Use 1 scholarly article